Johns Hopkins Digital Twins Improve VT Treatment in Trial

Researchers at Johns Hopkins University have pioneered the use of personalized digital replicas of patients' hearts to enhance the treatment of ventricular tachycardia, a life-threatening arrhythmia that contributes to approximately 300,000 sudden cardiac deaths annually in the United States. In the first FDA-approved clinical trial of this technology, known as the TWINVT study, doctors created virtual models to guide cardiac ablation procedures for 10 patients who had previously suffered heart attacks. The trial, involving participants with recurrent abnormal heart rhythms, resulted in faster, more precise interventions and complete long-term success in preventing arrhythmias, according to findings published recently in the New England Journal of Medicine.

Digital twins are advanced computational models that replicate an organ's structure and electrical behavior based on high-resolution imaging, such as contrast-enhanced MRI scans. For each patient in the trial, the Johns Hopkins team constructed a three-dimensional virtual heart that simulated how electrical signals traveled through damaged tissue, identifying the precise spots triggering the rapid, irregular beats...